Bladder cancer: issues requiring further research by I. A. Rozhkov, P. V. Bulychkin

Subjects: Get full text

Patterns of chemotherapy use with primary radiotherapy for localized bladder cancer in patients 65 or older by Fady Ghali, Sarah K. Holt, Elizabeth L. Koehne, Jonathan J. Chen, Emily S. Weg, Jay J. Liao, Jing Zeng, Petros Grivas, Petros Grivas, Jessica E. Hawley, Jessica E. Hawley, Andrew C. Hsieh, Andrew C. Hsieh, Robert Bruce Montgomery, Robert Bruce Montgomery, Jonathan L. Wright, Jonathan L. Wright

Subjects: Get full text

Trimodal therapy in T2‐4aN0M0 bladder cancer––How to select the best candidate? by Ofer N. Gofrit, Amichay Meirovitz, Stephen Frank, Igal Rabinovich, Hemda Luwisch, Vladimir Yutkin, Tzahi Neuman, Guy Hidas, Mordechai Duvdevani, Marc Wygoda

Subjects: Get full text

Oncological effectiveness of bladder-preserving trimodal therapy versus radical cystectomy for the treatment of muscle-invasive bladder cancer: a system review and meta-analysis by Xiaozhe Su, Caitao Dong, Wenbiao Liao, Wentao Liu

Subjects: Get full text

Bladder preservation protocols in the management of muscle-invasive bladder cancer: A systematic review by Srikanth Pentyala, R B Nerli, Shridhar C Ghagane, Murigendra B Hiremath

Subjects: Get full text

Trimodal organ‑preserving treatment of muscle‑invasive bladder cancer by A. V. Troianov, I. O. Dementev, I. N. Zaborsky, V. S. Chaykov, O. B. Karyakin, Yu. V. Gumenetskaya

Subjects: Get full text

Induction therapy with ipilimumab and nivolumab followed by consolidative chemoradiation as organ-sparing treatment in urothelial bladder cancer: study protocol of the INDIBLADE tr... by C.F. Stockem, J.J.J. Mellema, B.W.G. van Rhijn, T.N. Boellaard, M.L. van Montfoort, S. Balduzzi, J.L. Boormans, M. Franckena, R.P. Meijer, D.G.J. Robbrecht, B.B.M. Suelmann, E.E. Schaake, M.S. van der Heijden

Subjects: Get full text

Trimodal therapy versus radical cystectomy for cT2N0M0 urothelial muscle-invasive bladder cancer: Single-center experience by Moayid Fallatah, Ali S Alkahtani, Majed Alrumayyan, Mohammed F Alotaibi, Sultan Alkhateeb, Alaa Ahmed Mokhtar, Waleed Altaweel

Subjects: Get full text

Evaluation of Survival Outcomes With Trimodal Therapy as Primary Therapy for Non-organ-confined Bladder Cancer by Yadong Guo, Yadong Guo, Yadong Guo, Xiaoliang Jie, Xiaoliang Jie, Aihong Zhang, Wentao Zhang, Ruiliang Wang, Junfeng Zhang, Shiyu Mao, Yuan Wu, Yuan Wu, Yuan Wu, Longsheng Wang, Ziwei Zhang, Yang Yan, Ping Wang, Ping Wang, Xudong Yao, Xudong Yao, Xudong Yao

Subjects: Get full text

Outcomes for Muscle-invasive Bladder Cancer with Radical Cystectomy or Trimodal Therapy in US Veterans by Abhishek Kumar, Daniel R. Cherry, Patrick T. Courtney, Vinit Nalawade, Nikhil Kotha, Paul J. Riviere, Jason Efstathiou, Rana R. McKay, A. Karim Kader, Brent S. Rose, Tyler F. Stewart

Subjects: Get full text

Trimodal Therapy in the Treatment of Muscle-Invasive Bladder Cancer by Yongsoo Jo, Hyeong Dong Yuk

Subjects: Get full text

Conditional survival of trimodal therapy for nonmetastatic muscle‐invasive bladder cancer: A SEER database analysis by Wentai Shangguan, Jintao Hu, Yingwei Xie, Zhiliang Chen, Qiyu Zhong, Zaosong Zheng, Dingjun Zhu, Yishan Zhang, Jingying Yang, Jinli Han, Wenlian Xie

Subjects: Get full text

Trimodal therapy and surgical approaches in stage IIIA/N2 non-small cell lung cancer by Pin-Ching Hu, Jing-Yang Huang, Ya-Fu Cheng, Ching-Yuan Cheng, Chang-Lun Huang, Wei-Heng Hung, Bing-Yen Wang

Subjects: Get full text

Select octogenarians with stage IIIa non–small cell lung cancer can benefit from trimodality therapyCentral MessagePerspective by Andrew Tang, MD, MS, Andrew Feczko, MD, Sudish C. Murthy, MD, PhD, Siva Raja, MD, PhD, Alejandro Bribriesco, MD, Dean Schraufnagel, MD, Usman Ahmad, MD, Daniel P. Raymond, MD, Monisha Sudarshan, MD, MPH

Subjects: Get full text

Optimal surgical timing and radiotherapy dose for trimodality therapy in locally advanced non‐small cell lung cancer by James E. Han, Shaakir Hasan, J. Isabelle Choi, Robert H. Press, Charles B. Simone II

Subjects: Get full text

Risk stratification of postoperative cardiopulmonary toxicity after trimodality therapy for esophageal cancer by Roman O. Kowalchuk, Grant M. Spears, Lindsay K. Morris, Dawn Owen, Harry H. Yoon, Krishan Jethwa, Michael D. Chuong, Matthew J. Ferris, Michael G. Haddock, Christopher L. Hallemeier, Dennis Wigle, Steven H. Lin, Kenneth W. Merrell

Subjects: “…trimodality therapy…”
Get full text

Angiosarcoma of the seminal vesicle: a case report of long-term survival following multimodality therapy by Kenneth Chang, Terence T. Sio, Vishal S. Chandan, Matthew J. Iott, Christopher L. Hallemeier

Subjects: “…angiosarcoma, seminal vesicle, prostate, neoadjuvant, surgery, chemoradiation, trimodality therapy…”
Get full text

Editorial: Bladder preservation options for bladder cancer by Nancy B. Davis, Deepak Kilari, Elizabeth R. Kessler, Woodson W. Smelser

Subjects: Get full text

Comparison of trimodality therapy and neoadjuvant chemotherapy combined with radical cystectomy for the survival of muscle-invasive bladder cancer: a population-based analysis by Yi-Xin Zhou, Qian-Cheng Hu, Ya-Juan Zhu, Xiao-Li Mu, Ji-Yan Liu, Ye Chen

Subjects: Get full text

Adjuvant Chemoradiotherapy Associated with Improved Overall Survival in Resected Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy in Intensity-Modulated Radio... by Wing-Keen Yap, Ming-Chieh Shih, Yu-Chen Chang, Chia-Hsin Lin, Shih-Ming Huang, Tsung-You Tsai, Ching-Fu Chang, Chih-Chung Hsu, Chen-Kan Tseng, Miao-Fen Chen, Din-Li Tsan, Chi-Ting Liau, Ming-Mo Hou, Yin-Kai Chao, Chien-Hung Chiu, Tsung-Min Hung

Subjects: Get full text